drug – Investorempires.com

AbbVie tumbles after new schizophrenia drug fails two trials

Aptar Pharma buys Israeli drug delivery co SipNose

Roche falls while Novo, Lilly gain on weight-loss drug report (OTCQX:RHHBY)

Sanofi MS drug tolebrutinib misses goal in relapsing disease trials By Reuters

GSK to seek dismissal of Florida case against heartburn drug Zantac By Reuters

Viking obesity drug to rival Eli Lilly’s: report (NASDAQ:VKTX)

US FDA flags dosing risks from compounded versions of Novo’s weight-loss drug By Reuters

Eli Lilly to buy bowel disease drug developer Morphic for $3.2 billion By Reuters

New Alzheimer’s drug treatment from Eli Lillly wins FDA approval

Crypto Deposits to Chinese Drug Producers’ Addresses Double in Early 2024 Compared to 2023